BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2478015)

  • 21. Thromboembolism after hip surgery.
    Westermann K; Trentz O; Pretschner P; Mellmann J
    Int Orthop; 1981; 4(4):253-7. PubMed ID: 6164655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G
    N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding.
    Francis CW; Marder VJ; Evarts CM; Yaukoolbodi S
    JAMA; 1983 Jan; 249(3):374-8. PubMed ID: 6184493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The efficacy of low-dose heparin--warfarin anticoagulation prophylaxis after total hip replacement arthroplasty.
    Goss TP; Stinchfield FE; Cosgriff SW
    Clin Orthop Relat Res; 1979 Jun; (141):134-7. PubMed ID: 477094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prostheses.
    Francis CW; Marder VJ; Evarts CM
    Lancet; 1986 Apr; 1(8484):769-71. PubMed ID: 2421120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery.
    Taberner DA; Poller L; Thomson JM; Lemon G; Weighill FJ
    Br J Surg; 1989 Sep; 76(9):933-5. PubMed ID: 2804589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.
    Ryan DH; Crowther MA; Ginsberg JS; Francis CW
    Ann Intern Med; 1998 Feb; 128(4):270-6. PubMed ID: 9471929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts in the prevention, detection, and treatment of deep vein thrombosis in total hip and knee replacement.
    Yen D
    Curr Opin Rheumatol; 1992 Apr; 4(2):210-5. PubMed ID: 1581150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.
    Eriksson BI; Ekman S; Kalebo P; Zachrisson B; Bach D; Close P
    Lancet; 1996 Mar; 347(9002):635-9. PubMed ID: 8596376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.
    Eikelboom JW; Quinlan DJ; Douketis JD
    Lancet; 2001 Jul; 358(9275):9-15. PubMed ID: 11454370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolism after elective and post-traumatic hip surgery--a controlled prophylactic trial with dextran 70 and low-dose heparin.
    Bergqvist D; Efsing HO; Hallböök T; Hedlund T
    Acta Chir Scand; 1979; 145(4):213-8. PubMed ID: 386676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI; Ekman S; Lindbratt S; Baur M; Bach D; Torholm C; Kälebo P; Close P
    J Bone Joint Surg Am; 1997 Mar; 79(3):326-33. PubMed ID: 9070519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)].
    Hubens A; Peeters R
    Acta Chir Belg; 1976 Jul; 75(4):402-15. PubMed ID: 797205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombin III deficiency: clinical relevance and replacement therapy.
    Gallus AS
    Dev Biol Stand; 1987; 67():59-66. PubMed ID: 3609485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two warfarin regimens in the prevention of venous thrombosis following total knee replacement.
    Francis CW; Pellegrini VD; Leibert KM; Totterman S; Azodo MV; Harris CM; Cox C; Marder VJ
    Thromb Haemost; 1996 May; 75(5):706-11. PubMed ID: 8725709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
    Van Betsbrugge M
    Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement.
    Woolson ST
    J Bone Joint Surg Am; 1996 Nov; 78(11):1735-40. PubMed ID: 8934490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-operative plasma levels of thrombin-antithrombin III complexes correlate with the development of venous thrombosis after major hip or knee surgery.
    Ginsberg JS; Brill-Edwards P; Panju A; Patel A; McGinnis J; Smith F; Dale I; Johnston M; Ofosu F
    Thromb Haemost; 1995 Aug; 74(2):602-5. PubMed ID: 8584991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.